-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Repare Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2019 to Q3 2024.
- Repare Therapeutics Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$36.4M, a 5.33% increase year-over-year.
- Repare Therapeutics Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$93.7M, a 10.7% increase year-over-year.
- Repare Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$116M, a 487% decline from 2022.
- Repare Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$19.8M, a 81.8% increase from 2021.
- Repare Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$109M, a 100% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)